The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...

It is also the first clinical trial of the vaccine during an outbreak Kampala, Uganda | AGENCIES | In a global first, ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing ...

Makerere University, the Uganda Virus Research Institute and the WHO got the Ebola vaccine trial ready for dosing in just ...

In a global first, Uganda's Ministry of Health, the World Health Organization (WHO) and other partners today launched a first ever vaccine trial for Ebola from the Sudan species of the virus, and at ...

This is a critical achievement toward better pandemic preparedness and saving lives when outbreaks occur,” said Dr. Tedros ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...